Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2017 (2017), Article ID 5107485, 11 pages
https://doi.org/10.1155/2017/5107485
Research Article

Heterogeneous Responses of Ovarian Cancer Cells to Silver Nanoparticles as a Single Agent and in Combination with Cisplatin

1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA
2Salem College, Winston-Salem, NC 27101, USA
3Comprehensive Cancer Center of Wake Forest Baptist Medical Center, Winston-Salem, NC 27157, USA

Correspondence should be addressed to Ravi N. Singh

Received 18 January 2017; Accepted 26 March 2017; Published 26 April 2017

Academic Editor: Ilaria Fratoddi

Copyright © 2017 Cale D. Fahrenholtz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2015,” CA Cancer Journal for Clinicians, vol. 65, no. 1, pp. 5–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. Cancer Genome Atlas Research Network, “Integrated genomic analyses of ovarian carcinoma,” Nature, vol. 474, no. 7353, pp. 609–615, 2011. View at Google Scholar
  3. L. Kelland, “The resurgence of platinum-based cancer chemotherapy,” Nature Reviews Cancer, vol. 7, no. 8, pp. 573–584, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. K. Parmar, J. A. Ledermann, N. Colombo et al., “Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial,” The Lancet, vol. 361, no. 9375, pp. 2099–2106, 2003. View at Google Scholar
  5. O. C. Farokhzad and R. Langer, “Impact of nanotechnology on drug delivery,” ACS Nano, vol. 3, no. 1, pp. 16–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Brannon-Peppas and J. O. Blanchette, “Nanoparticle and targeted systems for cancer therapy,” Advanced Drug Delivery Reviews, vol. 56, no. 11, pp. 1649–1659, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Chen, C.-M. Han, G.-L. Su, Z.-J. Tang, S.-J. Su, and X.-W. Lin, “Randomized controlled trial of the absorbency of four dressings and their effects on the evaporation of burn wounds,” Chinese Medical Journal, vol. 120, no. 20, pp. 1788–1791, 2007. View at Google Scholar · View at Scopus
  8. P. Sanpui, A. Murugadoss, P. V. D. Prasad, S. S. Ghosh, and A. Chattopadhyay, “The antibacterial properties of a novel chitosan-Ag-nanoparticle composite,” International Journal of Food Microbiology, vol. 124, no. 2, pp. 142–146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Pal, Y. K. Tak, and J. M. Song, “Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli,” Applied and Environmental Microbiology, vol. 73, no. 6, pp. 1712–1720, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Lee, R. E. Cohen, and M. F. Rubner, “Antibacterial properties of Ag nanoparticle loaded multilayers and formation of magnetically directed antibacterial microparticles,” Langmuir, vol. 21, no. 21, pp. 9651–9659, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Furno, K. S. Morley, B. Wong et al., “Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection?” Journal of Antimicrobial Chemotherapy, vol. 54, no. 6, pp. 1019–1024, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Gurunathan, J. W. Han, V. Eppakayala, M. Jeyaraj, and J.-H. Kim, “Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells,” BioMed Research International, vol. 2013, Article ID 535796, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Jeyaraj, G. Sathishkumar, G. Sivanandhan et al., “Biogenic silver nanoparticles for cancer treatment: an experimental report,” Colloids and Surfaces B: Biointerfaces, vol. 106, pp. 86–92, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Liu, Y. Zhao, Q. Guo et al., “TAT-modified nanosilver for combating multidrug-resistant cancer,” Biomaterials, vol. 33, no. 26, pp. 6155–6161, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Locatelli, M. Naddaka, C. Uboldi et al., “Targeted delivery of silver nanoparticles and alisertib: in vitro and in vivo synergistic effect against glioblastoma,” Nanomedicine, vol. 9, no. 6, pp. 839–849, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Sharma, S. Chockalingam, P. Sanpui, A. Chattopadhyay, and S. S. Ghosh, “Silver nanoparticles impregnated alginate-chitosan-blended nanocarrier induces apoptosis in human glioblastoma cells,” Advanced Healthcare Materials, vol. 3, no. 1, pp. 106–114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Liu, Z. Huang, Z. Chen et al., “Silver nanoparticles: a novel radiation sensitizer for glioma?” Nanoscale, vol. 5, no. 23, pp. 11829–11836, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Miura and Y. Shinohara, “Cytotoxic effect and apoptosis induction by silver nanoparticles in HeLa cells,” Biochemical and Biophysical Research Communications, vol. 390, no. 3, pp. 733–737, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Kawata, M. Osawa, and S. Okabe, “In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells,” Environmental Science and Technology, vol. 43, no. 15, pp. 6046–6051, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Beer, R. Foldbjerg, Y. Hayashi, D. S. Sutherland, and H. Autrup, “Toxicity of silver nanoparticles—nanoparticle or silver ion?” Toxicology Letters, vol. 208, no. 3, pp. 286–292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Guo, Y. Zhao, Y. Zhang et al., “The cellular uptake and cytotoxic effect of silver nanoparticles on chronic myeloid leukemia cells,” Journal of Biomedical Nanotechnology, vol. 10, no. 4, pp. 669–678, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Guo, L. Zhu, Z. Huang et al., “Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions,” Biomaterials, vol. 34, no. 32, pp. 7884–7894, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. H. Hsin, C. F. Chen, S. Huang, T. S. Shih, P. S. Lai, and P. J. Chueh, “The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells,” Toxicology Letters, vol. 179, no. 3, pp. 130–139, 2008. View at Google Scholar
  24. H. K. Lim, P. V. Asharani, and M. P. Hande, “Enhanced genotoxicity of silver nanoparticles in DNA repair deficient mammalian cells,” Frontiers in Genetics, vol. 3, Article ID Article 104, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Swanner, J. Mims, D. L. Carroll et al., “Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells,” International Journal of Nanomedicine, vol. 10, pp. 3937–3953, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Matai, A. Sachdev, and P. Gopinath, “Multicomponent 5-fluorouracil loaded PAMAM stabilized-silver nanocomposites synergistically induce apoptosis in human cancer cells,” Biomaterials Science, vol. 3, no. 3, pp. 457–468, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Hekmat, A. A. Saboury, and A. Divsalar, “The effects of silver nanoparticles and doxorubicin combination on DNA structure and its antiproliferative effect against T47D and MCF7 cell lines,” Journal of Biomedical Nanotechnology, vol. 8, no. 6, pp. 968–982, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Piao, K. A. Kang, I. K. Lee et al., “Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis,” Toxicology Letters, vol. 201, no. 1, pp. 92–100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Galluzzi, L. Senovilla, I. Vitale et al., “Molecular mechanisms of cisplatin resistance,” Oncogene, vol. 31, no. 15, pp. 1869–1883, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Nakayama, K. Nakayama, Y. Shamima et al., “Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer,” Cancer, vol. 116, no. 11, pp. 2621–2634, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Q. Schafer and G. R. Buettner, “Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple,” Free Radical Biology and Medicine, vol. 30, no. 11, pp. 1191–1212, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Filomeni, G. Rotilio, and M. R. Ciriolo, “Glutathione disulfide induces apoptosis in U937 cells by a redox-mediated p38 MAP kinase pathway,” The FASEB Journal, vol. 17, no. 1, pp. 64–66, 2003. View at Google Scholar · View at Scopus
  33. A. Sharma, K. Singh, and A. Almasan, “Histone H2AX phosphorylation: a marker for DNA damage,” Methods in Molecular Biology, vol. 920, pp. 613–626, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. T.-C. Chou, “Drug combination studies and their synergy quantification using the chou-talalay method,” Cancer Research, vol. 70, no. 2, pp. 440–446, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Kong, J. H. Seog, L. M. Graham, and S. B. Lee, “Experimental considerations on the cytotoxicity of nanoparticles,” Nanomedicine, vol. 6, no. 5, pp. 929–941, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Recordati, M. De Maglie, S. Bianchessi et al., “Tissue distribution and acute toxicity of silver after single intravenous administration in mice: nano-specific and size-dependent effects,” Particle and Fibre Toxicology, vol. 13, no. 1, article 12, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. M. S. Anglesio, K. C. Wiegand, N. Melnyk et al., “Type-specific cell line models for type-specific ovarian cancer research,” PLoS ONE, vol. 8, no. 9, Article ID e72162, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. L. K. Mullany, K.-K. Wong, D. C. Marciano et al., “Specific TP53 mutants overrepresented in ovarian cancer impact CNV, TP53 activity, responses to nutlin-3a, and cell survival,” Neoplasia, vol. 17, no. 10, pp. 789–803, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. B. A. Davidson, J. M. Rubatt, D. L. Corcoran et al., “Differential angiogenic gene expression in TP53 wild-type and mutant ovarian cancer cell lines,” Frontiers in Oncology, vol. 4, article 163, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Reles, W. H. Wen, A. Schmider et al., “Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer,” Clinical Cancer Research, vol. 7, no. 10, pp. 2984–2997, 2001. View at Google Scholar · View at Scopus
  41. D. Kovács, N. Igaz, C. Keskeny et al., “Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and apoptosis,” Scientific Reports, vol. 6, Article ID 27902, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Davis, A. V. Tinker, and M. Friedlander, ““platinum resistant” ovarian cancer: what is it, who to treat and how to measure benefit?” Gynecologic Oncology, vol. 133, no. 3, pp. 624–631, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Pal, J. Permuth-Wey, A. Kumar, and T. A. Sellers, “Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology,” Clinical Cancer Research, vol. 14, no. 21, pp. 6847–6854, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Petrucelli, M. B. Daly, and G. L. Feldman, “Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2,” Genetics in Medicine, vol. 12, no. 5, pp. 245–259, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Alsop, S. Fereday, C. Meldrum et al., “BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian ovarian cancer study group,” Journal of Clinical Oncology, vol. 30, no. 21, pp. 2654–2663, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Helleman, I. L. van Staveren, W. N. M. Dinjens et al., “Mismatch repair and treatment resistance in ovarian cancer,” BMC Cancer, vol. 6, article 201, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. E.-J. Park, J. Yi, Y. Kim, K. Choi, and K. Park, “Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism,” Toxicology in Vitro, vol. 24, no. 3, pp. 872–878, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. D. He, S. Garg, and T. D. Waite, “H2O2-mediated oxidation of zero-valent silver and resultant interactions among silver nanoparticles, silver ions, and reactive oxygen species,” Langmuir, vol. 28, no. 27, pp. 10266–10275, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. W. H. De Jong, L. T. M. Van Der Ven, A. Sleijffers et al., “Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats,” Biomaterials, vol. 34, no. 33, pp. 8333–8343, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Huang, W. Lai, M. Cui et al., “An evaluation of blood compatibility of silver nanoparticles,” Scientific Reports, vol. 6, Article ID 25518, 2016. View at Publisher · View at Google Scholar · View at Scopus